ICAM1 and neoplasm: Thus, we hypothesise that the secretion of sICAM-1 by human tumours may hinder the interaction between ICAM-1 and CD11b/CD18, leading to the downregulation of CD11b expression on NK cells and thereby resulting in the DN NK-cell accumulation.